ライフサイエンスコーパス: disability-adjusted life year

1 ard for low-income countries (140 US dollars/disability-adjusted life-year).

2 SB intake (4.5% of diabetes mellitus-related disability-adjusted life years).

3 calculated from estimates of the value of a disability-adjusted life year.

4 emental cost-effectiveness ratio of $363 per disability-adjusted life-year.

5 e for an estimated annual loss of 70 million disability-adjusted life years.

6 able risk factor for worldwide mortality and disability-adjusted life years.

7 estimated combined burden of over 87 million disability-adjusted life years.

8 ts systems, quality-adjusted life-years, and disability-adjusted life-years.

9 l deaths, as well as approximately 3% of all disability-adjusted life-years.

10 reporting measures of incidence, burden, and disability-adjusted life-years.

11 global burden of IHD increased by 29 million disability-adjusted life-years (29% increase) between 19

12 lth burden and on the cost-effectiveness per disability-adjusted life-year and lives saved were calcu

13 aharan Africa will probably lose 2.3 million disability-adjusted life-years and US$3.5 billion of eco

14 Thirty-seven percent of disability-adjusted-life-years arise from human infectio

15 rk to calculate the proportion of deaths and disability adjusted life years attributable to PM2.5 exp

16 ll scenarios, the highest estimated cost per disability-adjusted life year averted (uniform strategy

17 estimates ranging from US$2.97 to $52.92 per disability-adjusted life year averted in the 15 countrie

18 ut 2,000 and 5,000 international dollars per disability-adjusted life year averted, and was consisten

19 iveness ratio (ICER) of $1.50 ($US 2010) per disability-adjusted life year averted.

20 ease model in order to explore the impact on disability-adjusted life years averted, program cost, an

21 fectiveness ratio (United States dollars per disability-adjusted life-year averted and dollars per li

22 cination was very cost effective (with every disability-adjusted life-year averted costing less than

23 The cost per disability-adjusted life-year averted for alternative "w

24 The discounted cost per disability-adjusted life-year averted for restricted, fl

25 ocietal perspective (saving US$4.0-300.0 per disability-adjusted life-year averted in the countries s

26 16, 2012, to estimate the costs and cost per disability-adjusted life-year averted of introducing Xpe

27 cost-effectiveness of US$959 (633-1,485) per disability-adjusted life-year averted over 10 y.

28 income countries was $88, $291, and $329 per disability-adjusted life-year averted, respectively, and

29 BTT was more cost-effective at $205 to $272/disability-adjusted life-year averted, which was $142 to

30 would be associated with a cost of $5.07 per disability-adjusted life-year averted.

31 sociated with a base case cost of $74.73 per disability-adjusted life-year averted.

32 ew infection averted, and $351 (290-424) per disability-adjusted life-year averted.

33 We estimated health effects (ie, disability-adjusted life-years averted) and resource imp

34 ese properties would result in >0.53 million disability-adjusted-life-years averted over 2022-2042, w

35 ompared with UC was $3428.71 to $6857.68 per disability-adjusted life year avoided, and $0.80 to $1.6

36 About 32.4% of the growth in global IHD disability-adjusted life-years between 1990 and 2010 was

37 the burden of disease (defined by death and disability-adjusted life years) by comparing two WHO reg

38 Disability-adjusted life years, combining years of life

39 ness was assessed using incremental cost per disability adjusted life year (DALY) averted compared ag

40 timate of US$94 (95% CrI: US$51, US$166) per Disability Adjusted Life Year (DALY) averted, PMI-funded

41 nalysis to calculate ranges for the cost per disability-adjusted life year (DALY) averted for each in

42 eliable and valid prevalence, incidence, and disability-adjusted life year (DALY) estimates of oral c

43 ic for setting public health priorities, the disability-adjusted life year (DALY), is unsuited to par

44 cal assessment and uses a standard unit, the disability-adjusted life year (DALY), to aid comparisons

45 We developed a disability-adjusted life year (DALY)-based estimate of t

46 (YLL), 4) years lost to disability (YLD), 5) disability-adjusted life years (DALY's), 6) direct costs

47 odity categories and range from 0.025 to 6.6 disability-adjusted life years (DALY) per million dollar

48 as burden of disease) on the order of 0.2-9 disability-adjusted life years (DALY) per year of operat

49 d both in terms of the cost of treatment per disability-adjusted life-year (DALY) averted (one DALY i

50 calculated the incremental cost (in US$) per disability-adjusted life-year (DALY) averted to compare

51 comparing the incremental cost of Avahan per disability-adjusted life-year (DALY) averted versus a no

52 (ICER) was calculated in 2014 US dollars per disability-adjusted life-year (DALY) averted.

53 Outcome measures were cost per disability-adjusted life-year (DALY) averted; cost per l

54 Disability-adjusted life-year (DALY) changes between 199

55 Published disability-adjusted life-year (DALY) estimates suggest t

56 st per HIV-1 infection averted, and cost per disability-adjusted life-year (DALY) saved.

57 ection averted, and the incremental cost per disability-adjusted life-year (DALY) saved.

58 averted, cost per case averted, and cost per disability-adjusted life-year (DALY).

59 f primary prevention alone saved 3.6 million disability-adjusted life-years (DALY) per annum at an in

60 ldhood and maternal underweight (138 million disability adjusted life years [DALY], 9.5%), unsafe sex

61 The median CER of circumcision ($13.78 per disability-adjusted life year [DALY]) was similar to tha

62 uct [GDP] per capita, and GDP per capita per disability-adjusted life-year [DALY]).

63 al and microbial hazards were assessed using disability adjusted life years (DALYs) as the common met

64 nt modelling was used to estimate changes in Disability Adjusted Life Years (DALYs) resulting from ch

65 number of infections, sequelae, deaths, and Disability Adjusted Life Years (DALYs), by age and regio

66 f foodborne illnesses, sequelae, deaths, and Disability Adjusted Life Years (DALYs), for all diseases

67 timate the global burden of FBDs in terms of Disability Adjusted Life Years (DALYs).

68 sed by the 31 hazards in 2010 was 33 million Disability Adjusted Life Years (DALYs); children under f

69 ne, the program averted 33.3 deaths or 244.5 disability adjusted life-years (DALYs) per 100 person-ye

70 burden of CT and cCMV in Belgium in terms of disability-adjusted life years (DALYs) and identify data

71 We assessed the burden of dengue illness as disability-adjusted life years (DALYs) and patient costs

72 veloped a model to investigate the number of disability-adjusted life years (DALYs) averted by a hydr

73 s, neonatal deaths, congenital syphilis, and disability-adjusted life years (DALYs) averted.

74 sociated unit costs; we quantified impact as disability-adjusted life years (DALYs) averted.

75 imum impact of different dietary patterns on disability-adjusted life years (DALYs) by using individu

76 he combined CVD and congenital heart anomaly disability-adjusted life years (DALYs) in the poorest co

77 from passive vaping was derived by computing disability-adjusted life years (DALYs) lost due to expos

78 HAZ, and WHZ, to minimize the mean number of disability-adjusted life years (DALYs) per child during

79 60 years) is highest in high-income regions, disability-adjusted life years (DALYs) per head are 40%

80 Leading causes of disability-adjusted life years (DALYs) predicted by the

81 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure diseas

82 m impacts are further aggregated to units of disability-adjusted life years (DALYs) using ReCiPe end

83 ountries studied, thus averting 8.34 million disability-adjusted life years (DALYs) yearly.

84 into incidences of cardiovascular diseases, disability-adjusted life years (DALYs), and life expecta

85 st 20% were prepared for 1990 for deaths and disability-adjusted life years (DALYs), by a procedure u

86 idual country, we estimated causes of death, disability-adjusted life years (DALYs), DALY-attributabl

87 Disability-adjusted life years (DALYs), years lived with

88 mortality, and disease burden as measured by disability-adjusted life years (DALYs).

89 We estimated deaths and disability-adjusted life years (DALYs; sum of years live

90 a much larger impact, averting 1.10 million disability-adjusted life-years (DALYs) and 25% of expect

91 We used disability-adjusted life-years (DALYs) and years lived w

92 Disability-adjusted life-years (DALYs) are a sum of the

93 ttributable fraction (PAF) of stroke-related disability-adjusted life-years (DALYs) associated with p

94 health-care costs, productivity losses, and disability-adjusted life-years (DALYs) attributable to p

95 Estimates of cases, deaths, and disability-adjusted life-years (DALYs) averted were calc

96 t with the highest incremental cost: 346 000 disability-adjusted life-years (DALYs) averted with an a

97 ted diseases by 1.42 million (1.38-1.48) and disability-adjusted life-years (DALYs) by 27.0 million (

98 We cross-tabulated the quantiles of disability-adjusted life-years (DALYs) by quintiles of D

99 of global numbers of illnesses, deaths, and disability-adjusted life-years (DALYs) due to listeriosi

100 ed annual and lifetime health-care costs and disability-adjusted life-years (DALYs) for individuals,

101 We calculated disability-adjusted life-years (DALYs) for low birthweig

102 spond to thresholds of $1,582 and $4,746 per disability-adjusted life-years (DALYs) for very cost-eff

103 d 103.1 million (90.8 million 115.1 million) disability-adjusted life-years (DALYs) in 2015, represen

104 2.4 million rotavirus deaths and >82 million disability-adjusted life-years (DALYs) in 64 of the 72 G

105 ), years lived with a disability (YLDs), and disability-adjusted life-years (DALYs) in England, the U

106 No studies have estimated disability-adjusted life-years (DALYs) lost due to hip f

107 mortality, mortality-to-incidence ratio, and disability-adjusted life-years (DALYs) lost, by age grou

108 ons to estimate the chronic heath impact, in disability-adjusted life-years (DALYs) lost, due to inha

109 easured the dengue health burden in terms of disability-adjusted life-years (DALYs) lost.

110 isease) with overall health gains of 420-826 disability-adjusted life-years (DALYs) per 100 000 popul

111 urement of the global burden of disease with disability-adjusted life-years (DALYs) requires disabili

112 The leading cause of disability-adjusted life-years (DALYs) was ischaemic hea

113 Disability-adjusted life-years (DALYs) were calculated a

114 Disability-adjusted life-years (DALYs) were estimated as

115 ths, 3.9% of years of life lost, and 3.8% of disability-adjusted life-years (DALYs) worldwide.

116 behavioural changes, we estimated 850 fewer disability-adjusted life-years (DALYs), and a saving of

117 (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life

118 (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life

119 s were costs, measles cases, measles deaths, disability-adjusted life-years (DALYs), and ICERs measur

120 rs lived with disability (YLDs) and 13.0% of disability-adjusted life-years (DALYs), instead of the e

121 (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), life expectancy,

122 y), avoid the loss of 3.73 and 2.19 million disability-adjusted life-years (DALYs), respectively, an

123 ife lived with disability (YLD), deaths, and disability-adjusted life-years (DALYs), with 95% uncerta

124 tality from scabies, YLDs were equivalent to disability-adjusted life-years (DALYs).

125 , the intervention was estimated to avert 19 disability-adjusted life-years (DALYs; 95% CI 16-21) and

126 patient admissions, 4300 deaths, and 136 000 disability-adjusted-life-years (DALYs).

127 of stroke mortality and burden (measured in disability-adjusted life years [DALYs]) were calculated

128 health benefits per million population (7332 disability-adjusted life-years [DALYs] in London, and 12

129 ined, including quality-adjusted life-years, disability-adjusted life-years, discounting, half-cycle

130 ainty interval, 9.6 million to 11.5 million) disability-adjusted life-years due to rheumatic heart di

131 esult in the annual loss of over 200 million disability-adjusted life years globally.

132 he potentially huge, largely undefined DALY (disability-adjusted life years) impact of early childhoo

133 er of IHD deaths since 1990, but >90% of IHD disability-adjusted life-years in 2010 were attributable

134 for 1.14 million (0.73 million-1.98 million) disability-adjusted life-years in 2013.

135 ces but averted approximately 5 million more disability-adjusted life-years in both China and India t

136 An estimated 90% of the 87 million disability-adjusted life-years incurred by surgical cond

137 nce, and disability-adjusted life-years (one disability-adjusted life-year is defined as the loss of

138 IHD rates in 74 countries (39%), and stroke disability-adjusted life-year loss rates exceeded IHD ra

139 We analyzed mortality and disability-adjusted life-year loss rates from stroke and

140 % higher to 27.2% lower than IHD, and stroke disability-adjusted life-year loss rates ranged from 6.2

141 cted for a subset of pollutants by computing disability-adjusted life years lost, using available tox

142 hat together encompass the largest number of disability-adjusted life-years lost in the United States

143 d at outcomes of EUHC not encompassed by the disability-adjusted life-year metric and related cost-ef

144 (2.3%) CHD deaths at an incremental cost per disability-adjusted life-year of $25 200.

145 days in 1994 and incidence, prevalence, and disability-adjusted life-years (one disability-adjusted

146 Changes in quality-adjusted life-years, disability-adjusted life-years, or survival and mortalit

147 sed by 32%, with an overall 28% reduction in disability-adjusted life years over the decade.

148 s of $75 million, while averting around 7000 disability-adjusted life-years over 20 years.

149 52,589 clinic visits (59%) and would save 58 disability-adjusted life-years per 1000 children annuall

150 stroke incidence, prevalence, mortality, and disability-adjusted life-years rates tend to decline fro

151 Vaccination would prevent the loss of 94,993 disability-adjusted life-years, resulting in an incremen

152 ctful stickers to be between $10 and $45 per disability-adjusted life-year saved.

153 3.7 million hospital visits, and 8.7 million disability-adjusted life-years, saving $188 million in t

154 ear averted, which was $142 to $182 less per disability-adjusted life-year than TTT or hybrid strateg

155 uce child mortality by 10-20%, at a cost per disability-adjusted life-year that is as low as any exis

156 sociated with funding, whereas the number of disability-adjusted life-years was strongly predictive o

157 A total of 8.5 (2.8, 19.2) million disability-adjusted life years were related to SSB intak

158 attributable to population growth, and total disability-adjusted life-years were attenuated by a 25.3

159 cycle impacts on human health (expressed in disability adjusted life years) which include other impo

160 m diseases, injuries, and risk factors using disability-adjusted life-years, which need a set of disa

161 eatest single cause of mortality and loss of disability-adjusted life years worldwide, and a substant

162 hosis is one of the main causes of death and disability-adjusted life-years worldwide.